{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-065638","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.870925+00:00","generated_at":"2026-05-22T08:45:47.999635+00:00","sec_items":["2.02","2.05","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biote Q1 net income $15.8M vs loss, revenue $49.0M, restructuring 16 employees","bullets":["Net income of $15.8M ($0.37 diluted EPS) vs net loss of $(5.7M) ($(0.12) per share) in Q1 2024.","Revenue $49.0M, up 4.7% YoY; dietary supplements +25.5%, procedure revenue -3.6%.","Adjusted EBITDA $13.8M (28.1% margin); gross profit margin 74.3% from vertical integration.","Board authorized restructuring on May 1, cutting 16 employees; completed May 5; charges $0.6-0.8M.","Company maintains 2025 financial outlook."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-065638","json":"https://secwatch.observer/filing/0000950170-25-065638.json","markdown":"https://secwatch.observer/filing/0000950170-25-065638.md","text":"https://secwatch.observer/filing/0000950170-25-065638.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000095017025065638/0000950170-25-065638-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000095017025065638/btmd-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T08:45:47.999635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3d1f0b7c0bd838cc11b7581d60f6c2d313fa5412","claim":"biote Corp. announced a restructuring with charges of approximately $0.6 to $0.8 million affecting commercial teams (16 employees).","evidence_excerpt":"maximize value from existing top-tier providers and strengthen accountability and discipline throughout the organization. The Company estimates that it will incur approximately $0.6 to $0.8 million in pre-tax restructuring charges, which represent future cash expenditures for the payment of one-time severance benefits and other associated costs. The Company","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000095017025065638/0000950170-25-065638-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $0.6 to $0.8 million"},{"label":"Affected area","value":"commercial teams"},{"label":"Headcount","value":"16 employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}